162 Participants Needed

Epilepsy Visit Planner for Epilepsy

QB
Overseen ByQueen Bolden
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
Must be taking: Antiepileptics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool. The project's hypotheses are: * Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group. * Patients that receive the Epilepsy Visit Planner will have improved quality of life scores. * The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study. Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on using a communication tool rather than changing medication.

What data supports the effectiveness of the treatment Epilepsy Visit Planner, Tablet-based Waiting Room Priority Communication Tool for epilepsy?

The research suggests that having a seizure action plan (SAP) can help patients and caregivers manage seizure emergencies more effectively, which may be similar to the benefits of using a communication tool like the Epilepsy Visit Planner. Additionally, telehealth tools have been shown to improve communication and care in pediatric epilepsy, indicating that technology-based solutions can be beneficial in managing epilepsy.12345

How does the Epilepsy Visit Planner treatment differ from other epilepsy treatments?

The Epilepsy Visit Planner treatment is unique because it focuses on personalized care planning and communication between patients and healthcare providers, rather than a specific medication or therapy. It emphasizes creating individualized seizure action plans to manage seizure clusters effectively, which is not typically a focus of standard epilepsy treatments.12678

Research Team

CH

Chloe Hill, MD

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for adults with drug-resistant epilepsy who are being treated at the University of Michigan's Epilepsy clinics. Participants must be able to complete study questionnaires in English and not have cognitive impairments that would prevent this.

Inclusion Criteria

I have epilepsy that doesn't respond to medication.
Participants receiving care through the Epilepsy clinics at the University of Michigan
University of Michigan epilepsy providers

Exclusion Criteria

I am under 18 years old.
I cannot complete questionnaires due to cognitive issues.
My epilepsy is not clearly drug-resistant.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline

Baseline assessments including Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI) and other measures

1 week
1 visit (in-person)

Intervention

Participants receive the Epilepsy Visit Planner tool and undergo assessments for feasibility and acceptability

3 months
Multiple visits (in-person and virtual)

Follow-up

Participants are monitored for quality of life and other outcomes 3 months after baseline

3 months

Treatment Details

Interventions

  • Epilepsy Visit Planner
Trial Overview The trial is testing a tablet-based tool called the 'Epilepsy Visit Planner' to see if it improves patient-provider communication and quality of life for epilepsy patients, compared to those who don't use the tool.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Standard care arm - patient participantsExperimental Treatment1 Intervention
This group will be enrolled first.
Group II: Intervention arm (Epilepsy Visit Planner) - provider participantsExperimental Treatment1 Intervention
Epilepsy providers will be recruited from the University of Michigan (approximately 10 providers).
Group III: Intervention arm (Epilepsy Visit Planner) - patient participantsExperimental Treatment2 Interventions
This group will be enrolled after the standard care arm enrollment is completed.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+

Findings from Research

Understanding individual seizure clusters is crucial for patients with epilepsy and their caregivers, as it enables prompt action to prevent severe complications like prolonged seizures or status epilepticus.
The introduction of Acute Seizure Action Plans (ASAPs) offers a standardized and customized approach for managing seizure emergencies, providing clear protocols for patients and caregivers to follow during seizure clusters.
Introduction to use of an acute seizure action plan for seizure clusters and guidance for implementation.Patel, AD., Becker, DA.[2022]
A new telehealth tool was developed to enhance communication among providers, researchers, patients, and families involved in pediatric epilepsy care, addressing the needs of a population facing significant healthcare disparities.
This tool enables in-home telemedicine appointments, which not only improves access to care for patients but also reduces costs for both families and hospital systems.
A Multimodal Telehealth Strategy to Improve Pediatric Epilepsy Care.Niemann, MH., Alvarado, MC., Camayd-Muñoz, C., et al.[2020]
Only 30% of the 408 surveyed patients with epilepsy reported having a seizure emergency plan, indicating low adoption despite existing guidance.
Patients with a plan tended to have more severe epilepsy symptoms, including more frequent seizures and higher rates of emergency room visits, suggesting that while plans are more common among those with severe cases, they could benefit all patients with epilepsy.
Seizure emergency plans: patient results from a cross-sectional epilepsy survey.Wheless, JW., Manjunath, R., Phelps, SJ., et al.[2008]

References

Introduction to use of an acute seizure action plan for seizure clusters and guidance for implementation. [2022]
A Multimodal Telehealth Strategy to Improve Pediatric Epilepsy Care. [2020]
Seizure emergency plans: patient results from a cross-sectional epilepsy survey. [2008]
Knowledge translation of an online tool to determine candidacy for epilepsy surgery evaluation. [2020]
Seizure action plans in the pediatric population with epilepsy: Uptake, determinants, and parental interest in a mobile application. [2021]
Neurologist-patient communication about epilepsy in the United States, Spain, and Germany. [2022]
Telephone review for people with epilepsy. [2018]
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study. [2020]